These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 16981966)
21. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol. Peyron ID; Britto IL; Benissan LB; Tardieu BZ Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605 [TBL] [Abstract][Full Text] [Related]
22. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023). Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M; Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834 [TBL] [Abstract][Full Text] [Related]
23. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma. Harrison LI; Novak CC; Needham MJ; Ratner P J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects. Kempsford R; Handel M; Mehta R; De Silva M; Daley-Yates P Respir Med; 2005 Apr; 99 Suppl A():S11-9. PubMed ID: 15777604 [TBL] [Abstract][Full Text] [Related]
25. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768 [TBL] [Abstract][Full Text] [Related]
27. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683 [TBL] [Abstract][Full Text] [Related]
28. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD. Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300 [TBL] [Abstract][Full Text] [Related]
29. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371 [TBL] [Abstract][Full Text] [Related]
30. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma. Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223 [TBL] [Abstract][Full Text] [Related]
31. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. Lipworth BJ; Fardon TC J Allergy Clin Immunol; 2004 Jan; 113(1):178; author reply 178-9. PubMed ID: 14713929 [No Abstract] [Full Text] [Related]
32. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler. Biswas R; Hanania NA; Sabharwal A J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430 [TBL] [Abstract][Full Text] [Related]
34. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [TBL] [Abstract][Full Text] [Related]
35. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. LaForce C; Weinstein C; Nathan RA; Weinstein SF; Staudinger H; Meltzer EO J Asthma; 2011 Aug; 48(6):625-31. PubMed ID: 21726121 [TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702 [TBL] [Abstract][Full Text] [Related]
37. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A; Szalai Z; Pullerits T; Radeczky E Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [TBL] [Abstract][Full Text] [Related]
38. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare. Nguyen WT; Stewart C; Fisher K; Tolley E; Lew DB; Self TH Allergy Asthma Proc; 2005; 26(2):129-34. PubMed ID: 15971472 [TBL] [Abstract][Full Text] [Related]
39. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. Balkissoon R; Make B COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147 [TBL] [Abstract][Full Text] [Related]
40. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Papi A; Paggiaro P; Nicolini G; Vignola AM; Fabbri LM; Allergy; 2007 Oct; 62(10):1182-8. PubMed ID: 17845589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]